Evolving NSCLC Landscape: Comparing Recent Updates in Neoadjuvant and Perioperative Immunotherapy

An expert comparison of recent data on neoadjuvant and perioperative immunotherapy in resectable early-stage NSCLC, including CheckMate 77T, CheckMate-816, and KEYNOTE-671.

Related Keywords

,Women Health ,Digital Health ,Population Health ,Chemotherapy ,Complete Response ,Adjuvant Therapy ,Pathologic Complete Response ,Checkmate 816 ,Immunotherapy ,Checkmate 77t ,Keynote 671 ,Neoadjuvant Phase ,Neoadjuvant Immune Checkpoint Inhibitor ,